News from decision resources A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( LSE:EXPN,OTC-PINK:EXPGY)

Oct 20, 2014, 14:00 ET
Decision Resources Group Logo.

The Age-Related Macular Degeneration Drug Market Will Grow to Nearly $9 Billion in 2023, Fueled in Part by the Anticipated Launch of the First Therapies for Geographic Atrophy

Decision Resources Group finds that the market for age-related macular degeneration (AMD) pharmacotherapies will expand 6 percent annually to reach...

Oct 20, 2014, 12:30 ET
Decision Resources Group Logo.

Asia Pacific Gastrointestinal Endoscopy Device Market Will Grow at 9 Percent Annually Through 2023

Decision Resources Group finds that the Asia Pacific gastrointestinal (GI) endoscopy device market will grow strongly through 2023 at a 9 percent...

Oct 16, 2014, 13:15 ET
Decision Resources Group Logo.

Despite Generic Erosion of Several Key Brands, the Renal Cell Carcinoma (RCC) Market Will Experience Modest Growth through 2023

Decision Resources Group finds that the market for renal cell carcinoma (RCC) therapies will grow to approximately $2.5 billion by 2023, despite...

Oct 16, 2014, 10:00 ET
Decision Resources Group Logo

Physicians in Both South Korea and Taiwan Anticipate Healthy Uptake of the Emerging SGLT-2 Inhibitors for Type 2 Diabetes Treatment, but Payers Predict a Tough P&R Environment

Decision Resources Group finds that, for the treatment of type 2 diabetes, over 90 percent of surveyed physicians in South Korea and Taiwan...

Oct 15, 2014, 12:00 ET
Decision Resources Group Logo.

In the Face of Sales Erosion of Key Brands by Novel Formulations, GlaxoSmithKline/Theravance's LABA/LAMA Anoro Will Become the Leading COPD Agent in 2023

Decision Resources Group finds that the emergence of the long-acting beta2 agonist (LABA)/long-acting muscarinic antagonist (LAMA) drug class will...

Oct 15, 2014, 11:00 ET
Decision Resources Group Logo.

While Rheumatologists Would Welcome Novel Biologics for the Treatment of Systemic Lupus Erythematosus (SLE), Reimbursement Challenges Are Expected

 Decision Resources Group finds that although use of biologics in SLE has increased in the past three years, largely due to uptake of...

Oct 15, 2014, 10:00 ET
Decision Resources Group Logo.

U.S. Reprocessed Device Market Will Reach Over $680 Million by 2023

 Decision Resources Group finds that the market for reprocessed devices in the United States will undergo robust growth, reaching a value of...

Oct 15, 2014, 09:00 ET
Decision Resources Group Logo.

Decision Resources Group Announces Its Spring Managed Markets Summit to be Held in New Orleans in March, 2015

 Decision Resources Group's 2015 Spring Managed Markets Summit (MMS) is a three-day conference dedicated to educating pharmaceutical and...

Oct 14, 2014, 11:32 ET
Decision Resources Group Logo

The Launch of New Therapies to Treat Niche Populations Will Drive 5 Percent Annual Sales Growth in the Parkinson's Disease (PD) Drug Market from 2013 to 2023

BURLINGTON, Mass., Oct. 14, 2014 /PRNewswire/ --  Decision Resources Group finds that the Parkinson's disease (PD) pharmacotherapy market...

Oct 09, 2014, 15:06 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Study Finds Strong Consumer Interest in Storing, Sharing Health Data - With Some Caveats, According to New Manhattan Research Study from Decision Resources Group

 Decision Resources Group finds that, as Apple, Samsung and Google field health and fitness data aggregators, 30 percent of online consumers...

Oct 09, 2014, 14:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

By 2028, One-Quarter of Total Pain Sales Will be Attributable to Novel Drug Classes

 Decision Resources Group finds that the overall pain market will maintain $38 billion in sales in 2028 across the major pharmaceutical...

Oct 09, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Spring 2015 Managed Markets Summit is Set For March 4-6, 2015

 Decision Resources Group's Spring 2015 Managed Markets Summit (MMS) is a three-day conference dedicated to educating pharmaceutical and...

Oct 09, 2014, 09:30 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Underpenetration Will Support Revenue Growth in the European Market for Orthopedic Extremity Devices

 Decision Resources Group finds that the European market for orthopedic extremity devices will remain a point of focus and expansion for...

Oct 09, 2014, 09:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The U.S. and European Gastrointestinal Endoscopy Device Markets Will Expand to Reach $3.5 Billion and $1.6 Billion, Respectively, By 2023

 Decision Resources Group finds that the markets for gastrointestinal (GI) endoscopy devices in the United States and Europe will expand to...

Oct 08, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Asthma Market Is Forecast to Remain Stable over the Next Decade, Despite Generic Erosion of Market Leading Asthma Therapies

 Decision Resources Group finds that the market for asthma will remain stable, increasing slightly from $15.1 billion in 2013 to $16.1 billion...

Oct 08, 2014, 11:30 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Percentage Of Rheumatoid Arthritis Patients Treated With Alternative Mechanism Of Action Agents Has Increased Compared With Last Year

 Decision Resources Group finds that despite the increasing percentage of rheumatoid arthritis (RA) patients treated with agents with a newer...

Oct 08, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Robust Growth in the Breast Cancer Market Will be Driven by An Increasing Incident Population and Uptake of Current Therapies as well as Entry of Emerging Premium-Priced Agents

Decision Resources Group finds that by 2023 an increasing incident population, continued uptake of current premium-priced drugs and the launch of...

Oct 07, 2014, 15:15 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Decision Resources Group Announces Its Managed Care Account Management Training Seminar to be Held Next Month in San Francisco

 Account Management Training (AMT) presented by Decision Resources Group is a three-day conference providing comprehensive, hands-on...

Oct 07, 2014, 12:07 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Majority of Surveyed Rheumatologists in Europe and the United States Expect to Prescribe Biosimilar Infliximab Within One Year of Launch

 Decision Resources Group finds that the majority of surveyed rheumatologists in France, Germany and the United States expect to prescribe...

Oct 06, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Asia Pacific Facial Injectable Market Set to Approach $1.9 Billion by 2022

 Decision Resources Group finds that the Asia Pacific market for facial injectables will grow quickly to approach $1.9 billion by 2022. While...